Post your clinical trial on JoinClinicalTrials.com to reach thousands of viewer daily. Our Clinical Trial Listings have consistently proven to be an ...
Conditions: GDM; Lactation Intervention: Diagnostic Test: Hyperinsulinemic-euglycemic clamp Sponsors: Yale University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Recruiting
Condition: Postpartum Smoking Relapse Interventions: Behavioral: Attentional retraining (AR); Behavioral: Visual probe (VP) Sponsors: Yale University; National Institute on Minority Health and Health Disparities (NIMHD) Recruiting
Condition: Prescription Drug Abuse (Not Dependent) Interventions: Drug: Oxycodone Medication First; Drug: Placebo First Sponsors: Yale University; National Institute on Drug Abuse (NIDA) Recruiting
Condition: Drug Dependence Intervention: Other: [11-C]OMAR Sponsors: Yale University; National Institutes of Health (NIH); National Institute on Drug Abuse (NIDA) Recruiting
Condition: Borderline Personality Disorder Interventions: Drug: Ketamine; Drug: Midazolam Sponsors: Yale University; Nathan Kline Institute for Psychiatric Research; American Foundation for Suicide Prevention Recruiting
Conditions: Schizophrenia; Cannabis Dependence; Prodromal for Psychotic Illness; Family History of Alcoholism; Healthy Control Intervention: Radiation: [11-C]OMAR Sponsors: Yale University; National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH) Recruiting
Conditions: Smoking; Schizophrenia Intervention: Drug: Physostigmine Sponsors: Yale University; National Institutes of Health (NIH); National Institute on Drug Abuse (NIDA) Recruiting
Condition: Tobacco Use Cessation Interventions: Behavioral: Real-Time Smoking Intervention; Behavioral: Standard Treatment Sponsors: Yale University; Patterson Trust Mentored Research Award: Clinical, Health Services and Policy Research Recruiting
Condition: Tobacco Use Interventions: Other: Cigarette Brand Switching; Other: E-cigarette Flavor Sponsors: Yale University; National Institute on Drug Abuse (NIDA); Food and Drug Administration (FDA) Recruiting
Conditions: Schizophrenia and Other Psychotic Disorders; Cannabis Use Disorder; Healthy Intervention: Radiation: [11C]APP311 Sponsor: Yale University Recruiting
Conditions: Breast Cancer; Chemotherapy Induced Peripheral Neuropathy; Paclitaxel Induced Neuropathy Intervention: Diagnostic Test: Quantitative measures of reduction in Chemotherapy Induced Neuropathy (CIPN) and Cognitive Impairment (CICI) in patients with stage I-III breast cancer Sponsor: Yale University Recruiting
Condition: Alcohol Use Interventions: Drug: Guanfacine ER; Other: Placebo Sponsors: Yale University; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Recruiting
Condition: Dementia Caregiving Intervention: Behavioral: Wish Outcome Obstacle Plan Sponsors: Yale University; National Institute on Aging (NIA) Recruiting
Condition: Alcohol Drinking Interventions: Drug: Propranolol; Drug: Placebo Sponsors: Yale University; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Recruiting
Condition: Alcohol Use Disorder Interventions: Behavioral: Standard treatment (ST) PLUS web-based CBT4CBT; Behavioral: Standard Treatment (ST) Sponsors: Yale University; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Recruiting
Condition: Breast Neoplasms Interventions: Behavioral: Dietary/Physical Activity intervention; Behavioral: Usual Care Sponsor: Yale University Recruiting
Conditions: Opioid-use Disorder; Harmful; Use, Alcohol Intervention: Drug: Nalmefene Sponsors: Yale University; First Pavlov State Medical University in St. Petersburg, Russia Recruiting
Condition: Squamous Cell Cancers of the Head and Neck Interventions: Drug: cetuximab; Drug: afatinib Sponsors: Yale University; National Comprehensive Cancer Network; Boehringer Ingelheim Recruiting
Conditions: Type 1 Diabetes; De Novo Lipogenesis Intervention: Diagnostic Test: Oral Glucose Tolerance Test Sponsors: Yale University; Juvenile Diabetes Research Foundation Recruiting
Condition: Type 1 Diabetes Interventions: Device: Follicular Euglycemic clamp; Device: Luteal Euglycemic clamp Sponsors: Yale University; The Leona M. and Harry B. Helmsley Charitable Trust Recruiting
Conditions: Hepatic Steatosis; Fatty Liver Intervention: Sponsors: Yale University; American Heart Association; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Recruiting
Conditions: Lung Cancer Screening; Smoking Cessation Interventions: Behavioral: Gain-framed messaging; Drug: Nicotine replacement therapy; Combination Product: Gain-framed messaging plus NRT; Behavioral: Counseling alone Sponsors: Medical University of South Carolina; National Cancer Institute (NCI) Recruiting
Conditions: Smoking Cessation; Biofeedback Interventions: Behavioral: personalized cessation care; Behavioral: bio feedback; Other: standard care Sponsor: Yale University Recruiting
Condition: Diabetes Mellitus, Type 1 Intervention: Sponsors: Joslin Diabetes Center; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Recruiting
Condition: Alcohol Use Disorder Interventions: Drug: ANS-6637; Drug: Placebo oral tablet Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) Recruiting
Condition: Antisocial Behavior Interventions: Behavioral: Multisystemic Therapy for Emerging Adults; Behavioral: Enhanced Treatment as Usual Sponsors: University of Massachusetts, Worcester; National Institute of Mental Health (NIMH); Oregon Social Learning Center; Connecticut Department of Children and Families; North American Family Institute; Court Support Services Division Recruiting
Condition: Cannabis Use Disorder Interventions: Drug: PF 04457845; Drug: Placebo Oral Tablet Sponsors: Yale University; Columbia University; Johns Hopkins University; Medical University of South Carolina Recruiting
Condition: Alcoholism Interventions: Drug: Perampanel; Drug: Placebo Sponsors: Virginia Commonwealth University; University of Connecticut; Yale University Recruiting
Conditions: Cardiotoxicity; Breast Cancer; Lymphoma; Sarcoma; Leukemia; Myeloma; Lung Cancer Intervention: Device: MyoStrain® Sponsors: Washington University School of Medicine; Myocardial Solutions Recruiting
Condition: Post-Traumatic Stress Disorder Interventions: Behavioral: Online Cognitive-Behavioral Therapy; Behavioral: Online Supportive Therapy Sponsors: Icahn School of Medicine at Mount Sinai; National Institute for Occupational Safety and Health (NIOSH/CDC) Recruiting
Condition: Alcohol Use Disorder Interventions: Drug: Zonisamide; Drug: Placebo Sponsors: Virginia Commonwealth University; University of Connecticut; Yale University; National Institute on Alcohol Abuse and Alcoholism (NIAAA); VA Connecticut Healthcare System Recruiting
Conditions: Breast Adenocarcinoma; Invasive Breast Carcinoma; Metastatic Breast Carcinoma; Metastatic Malignant Solid Neoplasm; Stage III Breast Cancer AJCC v7; Stage IIIA Breast Cancer AJCC v7; Stage IIIB Breast Cancer AJCC v7; Stage IIIC Breast Cancer AJCC v7; Stage IV Breast Cancer AJCC v6 and v7; Unresectable Solid Neoplasm Interventions: Drug: Entinostat; Biological: Ipilimumab; Biological: Nivolumab; Other: Pharmacogenomic Study; Other: Pharmacological Study Sponsor: National Cancer Institute (NCI) Recruiting
Conditions: Solid Tumor; HER-2 Protein Overexpression Interventions: Biological: ACTR T Cell Product; Drug: Trastuzumab Sponsor: Unum Therapeutics Inc. Recruiting
Conditions: Advanced or Metastatic Solid Tumors; Head and Neck Squamous Cell Carcinoma; Non-Small Cell Lung Cancer; Ovarian Cancer; Triple Negative Breast Cancer Intervention: Drug: NC318 Sponsor: NextCure, Inc. Recruiting
Conditions: COPD; HIV/AIDS Intervention: Behavioral: Proactive E-consult Sponsors: Seattle Institute for Biomedical and Clinical Research; VA Puget Sound Health Care System; Bronx Veterans Medical Research Foundation, Inc; Washington D.C. Veterans Affairs Medical Center; VA Eastern Colorado Health Care System; University of Colorado, Denver; VA Greater Los Angeles Healthcare System; Atlanta VA Medical Center; Baylor College of Medicine; Michael Debakey Veterans Affairs Medical Center; Yale University; VA Connecticut Healthcare System Recruiting
Conditions: Blasts 21-30 Percent of Bone Marrow Nucleated Cells; Myelodysplastic Syndrome Interventions: Drug: Entinostat; Biological: Pembrolizumab Sponsor: National Cancer Institute (NCI) Recruiting
Condition: Previously Treated Non-Small Cell Lung Cancer Intervention: Drug: Screening Platform Sponsors: Southwest Oncology Group; National Cancer Institute (NCI) Recruiting
Conditions: Anatomic Stage IV Breast Cancer AJCC v8; Estrogen Receptor Positive; HER2/Neu Negative; Progesterone Receptor Positive; Prognostic Stage IV Breast Cancer AJCC v8; Elevated CA15-3 or CEA or CA27-29 Interventions: Other: Usual care disease monitoring; Other: Serum Tumor Marker directed disease monitoring; Other: Quality-of-Life Assessment; Other: Anxiety Questionnaire Administration Sponsors: Southwest Oncology Group; National Cancer Institute (NCI) Recruiting
Conditions: Colon Adenocarcinoma; Colorectal Carcinoma; Rectal Adenocarcinoma; Stage III Colon Cancer AJCC v8; Stage III Rectal Cancer AJCC v8; Stage IIIA Colon Cancer AJCC v8; Stage IIIA Rectal Cancer AJCC v8; Stage IIIB Colon Cancer AJCC v8; Stage IIIB Rectal Cancer AJCC v8; Stage IIIC Colon Cancer AJCC v8; Stage IIIC Rectal Cancer AJCC v8; Stage IV Colon Cancer AJCC v8; Stage IV Rectal Cancer AJCC v8; Stage IVA Colon Cancer AJCC v8; Stage IVA Rectal Cancer AJCC v8; Stage IVB Colon Cancer AJCC v8; Stage IVB Rectal Cancer AJCC v8; Stage IVC Colon Cancer AJCC v8; Stage IVC Rectal Cancer AJCC v8 Intervention: Drug: Savolitinib Sponsor: National Cancer Institute (NCI) Recruiting
Conditions: Advanced Malignant Solid Neoplasm; Glioblastoma; Recurrent Cholangiocarcinoma; Recurrent Glioma; Recurrent Malignant Solid Neoplasm; WHO Grade II Glioma; WHO Grade III Glioma Intervention: Drug: Olaparib Sponsor: National Cancer Institute (NCI) Recruiting
Conditions: Metastatic Pancreatic Adenocarcinoma; Pancreatic Ductal Adenocarcinoma; Stage III Breast Cancer AJCC v7; Stage III Lung Non-Small Cell Cancer AJCC v7; Stage III Lung Small Cell Carcinoma AJCC v7; Stage III Pancreatic Cancer AJCC v6 and v7; Stage IIIA Breast Cancer AJCC v7; Stage IIIA Lung Non-Small Cell Cancer AJCC v7; Stage IIIA Lung Small Cell Carcinoma AJCC v7; Stage IIIB Breast Cancer AJCC v7; Stage IIIB Lung Non-Small Cell Cancer AJCC v7; Stage IIIB Lung Small Cell Carcinoma AJCC v7; Stage IIIC Breast Cancer AJCC v7; Stage IV Breast Cancer AJCC v6 and v7; Stage IV Lung Non-Small Cell Cancer AJCC v7; Stage IV Lung Small Cell Carcinoma AJCC v7; Stage IV Pancreatic Cancer AJCC v6 and v7; Triple-Negative Breast Carcinoma; Unresectable Pancreatic Carcinoma Interventions: Other: 18F-Fluoromisonidazole; Drug: Cediranib; Drug: Cediranib Maleate; Other: Laboratory Biomarker Analysis; Drug: Olaparib; Procedure: Positron Emission Tomography Sponsors: National Cancer Institute (NCI); AstraZeneca Recruiting
Conditions: Coronary Artery Disease; Ischemic Heart Disease; Non ST Segment Elevation Myocardial Infarction Interventions: Device: Orbital Atherectomy; Device: Balloon Sponsors: Cardiovascular Systems Inc; Cardiovascular Research Foundation, New York Recruiting
Conditions: Invasive Breast Carcinoma; Stage 0 Breast Cancer AJCC v6 and v7; Stage I Breast Cancer AJCC v7; Stage IA Breast Cancer AJCC v7; Stage IB Breast Cancer AJCC v7; Stage II Breast Cancer AJCC v6 and v7; Stage IIA Breast Cancer AJCC v6 and v7; Stage IIB Breast Cancer AJCC v6 and v7; Stage III Breast Cancer AJCC v7; Stage IIIA Breast Cancer AJCC v7; Stage IIIB Breast Cancer AJCC v7; Stage IIIC Breast Cancer AJCC v7; Triple-Negative Breast Carcinoma Interventions: Other: Laboratory Biomarker Analysis; Other: Patient Observation; Biological: Pembrolizumab; Other: Quality-of-Life Assessment; Other: Questionnaire Administration; Radiation: Radiation Therapy Sponsor: National Cancer Institute (NCI) Recruiting
Condition: Node Positive HER2 Negative Breast Cancer Interventions: Other: Placebo; Drug: Aspirin Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI); United States Department of Defense; Bayer; Canadian Cancer Trials Group Recruiting
Conditions: Locally Advanced Unresectable Breast Carcinoma; Metastatic Breast Carcinoma; Stage III Breast Cancer AJCC v7; Stage IIIA Breast Cancer AJCC v7; Stage IIIB Breast Cancer AJCC v7; Stage IIIC Breast Cancer AJCC v7; Stage IV Breast Cancer AJCC v6 and v7 Interventions: Drug: Atezolizumab; Drug: Olaparib; Other: Questionnaire Administration Sponsor: National Cancer Institute (NCI) Recruiting
Conditions: Stage III Renal Cell Cancer AJCC v7; Stage IV Renal Cell Cancer AJCC v7; Type 1 Papillary Renal Cell Carcinoma; Type 2 Papillary Renal Cell Carcinoma; Unresectable Renal Cell Carcinoma Interventions: Drug: Cabozantinib; Drug: Cabozantinib S-malate; Drug: Crizotinib; Drug: Savolitinib; Drug: Sunitinib; Drug: Sunitinib Malate Sponsors: National Cancer Institute (NCI); Canadian Cancer Trials Group Recruiting
Conditions: Stage IB Breast Cancer; Stage II Breast Cancer Interventions: Radiation: regional nodal XRT; Radiation: chestwall XRT; Radiation: WBI Sponsors: NSABP Foundation Inc; National Cancer Institute (NCI); Radiation Therapy Oncology Group Recruiting
Conditions: Estrogen Receptor-negative Breast Cancer; Progesterone Receptor-negative Breast Cancer; Stage IA Breast Cancer; Stage IB Breast Cancer; Stage II Breast Cancer; Triple-negative Breast Cancer Interventions: Procedure: Breast surgery; Procedure: Magnetic resonance imaging; Procedure: Mammography Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI); American College of Radiology Imaging Network Recruiting
Condition: Infertility Interventions: Drug: MENOPUR solution for injection in pre-filled pen, 1200 IU/1.92 mL; Drug: MENOPUR powder and solvent for solution for injection, 75 IU; Other: Placebo (for MENOPUR solution for injection in pre-filled pen); Other: Placebo (for MENOPUR powder and solvent for solution for injection) Sponsor: Ferring Pharmaceuticals Recruiting
Condition: Pancreatic Cyst Intervention: Sponsors: Ohio State University; American College of Gastroenterology; The National Pancreas Foundation Recruiting
Condition: Early Breast Cancer Intervention: Other: Endocrine therapy interruption Sponsors: International Breast Cancer Study Group; Alliance for Clinical Trials in Oncology; Canadian Cancer Trials Group; Breast International Group Recruiting
Conditions: Solid Tumor, Adult; Triple Negative Breast Cancer; Head and Neck Squamous Cell Carcinoma; Non Small Cell Lung Cancer Intervention: Drug: AVID100 IV Sponsor: Formation Biologics Recruiting